Article
Clinical phenotype of severe and moderate haemophilia: Who should receive prophylaxis and what is the target trough level?
Haemophilia : the official journal of the World Federation of Hemophilia - 1 Mar 2021
Collins Peter W, Obaji Samya G, Roberts Heledd, Gorsani Deepan, Rayment Rachel
Abstract excerpt
INTRODUCTION: One of the most often stated tenets of haemophilia care is that prophylaxis converts a person from a severe to a moderate phenotype. In this review, we argue that this is not an accurate assumption and that people on prophylaxis predominantly have factor VIII/IX levels in the mild range. MODERATE HAEMOPHILIA AND PROPHYLAXIS: People with moderate haemophilia, who are treating with on-demand regimens,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
